3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
14
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Fatigue
5
Prostatic Neoplasms
4
Depression
4
Vomiting
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Rectal Neoplasms
3
Neoplasms
3
Nausea
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anxiety Disorders
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Pain
2
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms, Male
2
Anus Neoplasms
2
Urinary Bladder Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Stress, Psychological
1
Sleep Wake Disorders
1
Sezary Syndrome
1
Interventions
Hyperthermic Intraperitoneal Chemotherapy
17
Cisplatin
12
Oxaliplatin
10
Cytoreduction Surgical Procedures
10
Fluorouracil
9
Paclitaxel
8
Mitomycin
8
Leucovorin
6
Surgical Procedures, Operative
4
Doxorubicin
3
Observation
2
Neoadjuvant Therapy
2
Laparoscopy
2
Indocyanine Green
2
Docetaxel
2
Control Groups
2
Chemotherapy, Adjuvant
2
Carboplatin
2
Capecitabine
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
sodium thiosulfate
1
pembrolizumab
1
nilotinib
1
lobaplatin
1
irinotecan sucrosofate
1
genexol-PM
1
durvalumab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Therapeutics
×
Gastrointestinal
×
Clear all
NCT02840331
2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3
Unknown
50 enrolled